# Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

> **NCT00916695** · PHASE4 · UNKNOWN · sponsor: **Spanish Society of Cardiology** · enrollment: 332 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.

## Key facts

- **NCT ID:** NCT00916695
- **Lead sponsor:** Spanish Society of Cardiology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2009-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916695, "Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00916695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*